Intrinsic Value of S&P & Nasdaq Contact Us

Nutranomics, Inc. NNRX OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
23/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Nutranomics, Inc. (NNRX) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 21/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is -108% (-61.3 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

NNRX SharesGrow Score Overview

46/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.00005-0.0001
Volume300K
Avg Volume (30D)400.01K
Market Cap$816.23K
Beta (1Y)-0.06
Share Statistics
Shares Outstanding$16.32B
IPO Date2013-04-16
Employees1
CEOJonathan Bishop
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS67060H1086

Price Chart

NNRX
Nutranomics, Inc.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message